共 50 条
- [43] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma Journal of Neuro-Oncology, 2015, 122 : 135 - 143
- [50] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 939 - 939